Incorporation of 5-Iodouracil labelled with Iodine-131 into the Deoxyribonucleic Acid of Human Leukæmic Leucocytes following in vivo Administration of 5-Iododeoxyuridine labelled with Iodine-131

Nature ◽  
1959 ◽  
Vol 183 (4676) ◽  
pp. 1686-1687 ◽  
Author(s):  
M. L. EIDINOFF ◽  
L. CHEONG ◽  
E. GAMBETTA GURPIDE ◽  
R. S. BENUA ◽  
R. R. ELLISON
1983 ◽  
Vol 50 (03) ◽  
pp. 652-655 ◽  
Author(s):  
F Bauer ◽  
P Schulz ◽  
G Reber ◽  
C A Bouvier

SummaryThree mucopolysaccharides (MPS) used in the treatment of degenerative joint disease were compared to heparin to establish their relative potencies on 3 coagulation tests, the aPTT, the antifactor X a activity and the dilute thrombin time. One of the compounds, Arteparon®, was one fourth as potent as heparin on the aPTT, but had little or no influence on the 2 other tests. Further in vitro studies suggested that Arteparon® acted at a higher level than factor Xa generation in the intrinsic amplification system and that its effect was independent of antithrombin III. In vivo administration of Arteparon® confirmed its anticoagulant properties, which raises the question of the clinical use of this MPS.


Cells ◽  
2021 ◽  
Vol 10 (1) ◽  
pp. 132
Author(s):  
Johanna Simon ◽  
Gabor Kuhn ◽  
Michael Fichter ◽  
Stephan Gehring ◽  
Katharina Landfester ◽  
...  

Understanding the behavior of nanoparticles upon contact with a physiological environment is of urgent need in order to improve their properties for a successful therapeutic application. Most commonly, the interaction of nanoparticles with plasma proteins are studied under in vitro conditions. However, this has been shown to not reflect the complex situation after in vivo administration. Therefore, here we focused on the investigation of magnetic nanoparticles with blood proteins under in vivo conditions. Importantly, we observed a radically different proteome in vivo in comparison to the in vitro situation underlining the significance of in vivo protein corona studies. Next to this, we found that the in vivo corona profile does not significantly change over time. To mimic the in vivo situation, we established an approach, which we termed “ex vivo” as it uses whole blood freshly prepared from an animal. Overall, we present a comprehensive analysis focusing on the interaction between nanoparticles and blood proteins under in vivo conditions and how to mimic this situation with our ex vivo approach. This knowledge is needed to characterize the true biological identity of nanoparticles.


1961 ◽  
Vol 39 (6) ◽  
pp. 1043-1054 ◽  
Author(s):  
D. K. Myers ◽  
C. Anne Hemphill ◽  
Constance M. Townsend

Deoxycytidylate deaminase activity and net synthesis of deoxyribonucleic acid (DNA) in vivo were found to increase at approximately the same time during the early stages of liver regeneration. However, deaminase activity in the regenerating liver remained at a high level for 1 day after DNA synthesis had slowed down again during the later stages of regeneration. The increase in deaminase activity was restricted as a result of exposure to 600 r X radiation during early regeneration, but this effect only became evident 11–16 hours after the irradiation. Irradiation on the second day after partial hepatectomy, when deaminase levels in control regenerating livers were relatively constant, failed to affect the deaminase activity immediately but did produce a 40–50% decrease in activity 11–16 hours later. Other antimitotic agents, e.g., colchicine, had little effect on deaminase activity.


1993 ◽  
Vol 149 (1) ◽  
pp. 39-49 ◽  
Author(s):  
Jolanta E. Kunicka ◽  
Mary Anne Talle ◽  
Georgetta H. Denhardt ◽  
Martha Brown ◽  
Laura A. Prince ◽  
...  

1966 ◽  
Vol 44 (12) ◽  
pp. 1571-1575 ◽  
Author(s):  
K. D. Chaudhary ◽  
A. Lemonde

The in vivo synthesis of deoxyribonucleic acid (DNA), as shown by the rate of incorporation of14C-thymidine, has been investigated at different stages in the life cycle of Tribolium confusum. During the larval period, a close similarity is observed between the rate of DNA synthesis and the pattern of growth. The pupal stage, which is a non-growth phase, is characterized by a cessation of DNA synthesis. During the larval growth phase, although the 3-day-old larvae have the lowest and the 13-day-old have the highest rate of DNA synthesis, the rate of DNA degradation in the older larvae is almost twice as great as that of the younger larvae. These findings are consistent with the observed total concentration of DNA of the insect at these stages.


Sign in / Sign up

Export Citation Format

Share Document